Skip to main content

Table 1 Patients' characteristics.

From: Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures

UPN

Age/Sex

Tumor (histotype)

Stage/grade at diagnosis

Previous treatments

WBC×103/μl (PB/LK)*

Lymphocytes×103/μl (PB/LK)*

1

30/F

Melanoma

Advanced, metastatic disease

Surgery, chemotherapy

4.8/55.1

1.19/28.82

2

62/F

Cervical cancer (squamous)

FIGO IIB

Neoadjuvant radiochemotherapy, radical surgery, chemotherapy (2 lines)

5.0/66.2

1.28/33.9

3

44/F

Cervical cancer (squamous)

FIGO IB

Radical surgery, adjuvant radiochemotherapy, chemotherapy (4 lines)

5.52/29.8

0.69/14.66

4

55/F

Cervical cancer (squamous)

FIGO IIIB

Radiochemotherapy, chemotherapy (3 lines)

5.41/51.6

1.52/22.14

  1. WBC = white blood cells; PB = peripheral blood; LK = leukapheresis product.
  2. *Blood cell counts were obtained at patient enrolment.